Koyfin Home > Directory > Health Care > Aimmune Therap > Long-Term Debt

Aimmune Therap Long-Term Debt Chart (AIMT)

Aimmune Therap annual/quarterly Long-Term Debt from 2019 to 2020.
  • Aimmune Therap Long-Term Debt for the quarter ending June 06, 2020 was $131m a 69.74% increase of 92m year over year
  • Aimmune Therap Long-Term Debt for the last 12 months ending June 06, 2020 was $131m a 69.74% increase of 92m year over year
Other Cash Flow Metrics:
  • Aimmune Therap Cash Flow from Operations for the quarter ending September 09, 2018 was $-41m a 22.62% decrease of -9m year over year
  • Aimmune Therap Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-25m a 30.11% decrease of -7m year over year
View Chart On Koyfin

Quarterly AIMT Long-Term Debt Data

06/2020$131m
03/2020$128m
12/2019$41m
09/2019$40m
06/2019$39m
03/2019$37m

Annual AIMT Long-Term Debt Data

2019$41m